QI
AGN

Quotient Investors’s Allergan plc AGN Stock Holding History

Quotient Investors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,252
Closed -$289K – 226
2016
Q2 		$289K Sell
1,252
-1,105
-47% -$255K 0.14% 177
2016
Q1 		$632K Sell
2,357
-6
-0.3% -$1.72K 0.23% 114
2015
Q4 		$738K Sell
2,363
-3,900
-62% -$1.16M 0.28% 95
2015
Q3 		$1.7M Buy
+6,263
New +$1.92M 0.38% 68
2015
Q2 		– Sell
-994
Closed -$296K – 287
2015
Q1 		$296K Buy
+994
New +$283K 0.04% 195

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Quotient Investors's AGN Position: Q3 2016 in Review

Quotient Investors sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 1,252 shares — an estimated $289K sold.

Quotient Investors first reported a position in AGN in Q1 2015 and held it in 5 quarters. The position peaked at $1.7M in Q3 2015. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • Quotient Investors reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • Quotient Investors sold 1,252 Allergan plc shares in Q3 2016, an estimated $289K.
  • Quotient Investors first reported a position in Allergan plc in Q1 2015 and held it in 5 quarters.
  • Quotient Investors's Allergan plc position peaked at $1.7M in Q3 2015.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Quotient Investors's 13F filing for Q3 2016, filed 19 Oct 2016.